- Pharmacology
- Allergy, Immunology, and ENT
- Cardiology
- Emergency Medicine
- Endocrinology
- Adolescent Medicine
- Gastroenterology
- Infectious Diseases
- Neurology
- OB/GYN
- Practice Improvement
- Gynecology
- Respiratory
- Dermatology
- Mental, Behavioral and Development Health
- Oncology
- Rheumatology
- Sexual Health
- Pain
Johnson & Johnson recalls infant gas relief drops
Johnson & Johnson-Merck Consumer Pharmaceuticals company is voluntarily recalling approximately 12,000 units of Infants' Mylicon Gas Relief Dye-Free Drops (simethicone-antigas), according to the FDA.
Johnson & Johnson-Merck Consumer Pharmaceuticals company is voluntarily recalling approximately 12,000 units of Infants' Mylicon Gas Relief Dye-Free Drops (simethicone-antigas), according to the FDA.
The non-staining drops were sold in 1 oz. plastic bottles and were distributed after October 5, 2008. nationwide. The consumer recall is meant as a precaution after determining that some bottles could include metal fragments that were generated during the manufacturing process.
The FDA states that if any medical events resulting from use of the recalled products were to occur, most would be expected to be temporary and resolve without medical treatment. However, consumers who purchased two specific lots of this product are being advised to stop using the product and contact the manufacturer for further instructions.
The full FDA recall announcement, as well as contact information for consumers, can be found on the FDA Web site.
The benefits of concurrent fetal and maternal heart rate monitoring
April 17th 2024A recent study revealed that employing maternal heart rate monitoring alongside fetal heart rate monitoring during labor significantly decreases the incidence of neonatal encephalopathy and severe neonatal acidemia.
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
